A forgotten frontier: spinal cord stimulation for iatrogenic and traumatic peripheral neuropathic pain
The current study demonstrates that SCS is a promising treatment modality for patients with traumatic and/or iatrogenic PN. Prospective trials comparing SCS to treatments like PNS and DRG stimulation are essential to substantiate its efficacy, expand its indications, and inform future clinical guidelines for patients with intractable traumatic or iatrogenic peripheral neuropathy.
Authors
- Heinrich Moser
- Christopher L Robinson
- R. Jason Yong (ORCID: https://orcid.org/0000-0001-6960-9621)
- Robert van Dongen (ORCID: https://orcid.org/0000-0002-4437-5600)
- Erkan Kurt (ORCID: https://orcid.org/0000-0003-3768-4007)
- Hisse Arnts (ORCID: https://orcid.org/0000-0003-4454-5056)
- Linda Kollenburg (ORCID: https://orcid.org/0009-0004-1044-2838)
- Frank van Haren (ORCID: https://orcid.org/0000-0002-6591-0246)
- Inge Arnts (ORCID: https://orcid.org/0009-0002-1140-947X)
- Mark van Ooijen
Institutions
- Brigham and Women's Hospital (US)
- Johns Hopkins University (US)
- Radboud University Nijmegen (NL)
- Johns Hopkins Medicine (US)
- Radboud University Medical Center (NL)
- Radboud Institute for Molecular Life Sciences (NL)
Publication Details
- Journal
- Frontiers in Pain Research
- Published
- 2025-11-13
- DOI
- https://doi.org/10.3389/fpain.2025.1661520
- Primary Topic
- Pain Management and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00